Bosh sahifaBBN • SWX
add
Bellevue Group AG
Yopilish kursi
14,75 CHF
Kunlik diapazon
14,50 CHF - 14,80 CHF
Yillik diapazon
11,05 CHF - 24,30 CHF
Bozor kapitalizatsiyasi
195,19 mln CHF
Oʻrtacha hajm
9,95 ming
Narx/foyda
13,08
Dividend daromadliligi
7,93%
Asosiy maydon
SWX
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
(CHF) | iyn, 2024info | Y/Y qiyosi |
---|---|---|
Daromad | 18,41 mln | -11,31% |
Joriy xarajat | 13,73 mln | -10,56% |
Sof foyda | 3,72 mln | -7,22% |
Sof foyda marjasi | 20,18 | 4,61% |
Har bir ulushga tushum | — | — |
EBITDA | — | — |
Amaldagi soliq stavkasi | 17,26% | — |
Balans
Jami aktivlari
Jami passivlari
(CHF) | iyn, 2024info | Y/Y qiyosi |
---|---|---|
Naqd pul va qisqa investitsiyalar | 30,49 mln | 100,63% |
Jami aktivlari | 138,75 mln | -4,69% |
Jami passivlari | 22,05 mln | -24,81% |
Umumiy kapital | 116,70 mln | — |
Tarqatilgan aksiyalar | 13,20 mln | — |
Narxi/balansdagi bahosi | 1,67 | — |
Aktivlardan daromad | 10,71% | — |
Kapitaldan daromad | — | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
(CHF) | iyn, 2024info | Y/Y qiyosi |
---|---|---|
Sof foyda | 3,72 mln | -7,22% |
Operatsiyalardan naqd pul | 3,65 mln | 137,31% |
Sarmoyadan naqd pul | — | — |
Moliyadan naqd pul | -8,10 mln | 45,85% |
Naqd pulning sof oʻzgarishi | -4,17 mln | 83,13% |
Boʻsh pul | — | — |
Haqida
Bellevue Group AG, headquartered in Zurich, is a listed investment management corporation from Switzerland. Bellevue Group consists of the subsidiaries Bellevue Asset Management, Bellevue Private Markets and StarCapital. It has 9,6 billion Swiss francs Assets Under Management Around 80% of clients assets are in healthcare investments. Bellevue Group is also active in alternative investments and private equity, including co-investments in private domestic small and medium-sized enterprises. In this business area, client assets under management were 1.0 billion francs as of mid-2021.
Bellevue Group is among the largest investors in the health care segment worldwide. It has subsidiaries in Germany, UK and USA, and is focusing on platform companies with products in phase two trials or later who preferably develop technologies that can be applied in multiple ways. One of the Bellevue Asset Management teams manages the BB Biotech investment company. The former investment company BB Medtech, which was converted into an equity fund at the end of September 2009, is also managed by Bellevue Asset Management. Wikipedia
CEO
Tashkil etilgan
1993
Sayt
Xodimlar soni
88